Total Funding
60
43
Total FundingSeries C raised
Growth Score 60 in past quarter
-10 pts
Heat Score 43 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
56786
PolyActiva develops products that enable drug release from medical devices.
- Jerry St. Peter: CEOPast Role: Santen, President, Chief Executive Officer and Board Director
- Chris Nave: Chairman and Non-Executive DirectorPast Role: Uniseed, Investment Manager
About the Company
PolyActiva has developed proprietary drug-polymer conjugate technology that enables site-specific drug delivery from medical device components such as ocular implants, intra-articular gel implants, and drug-eluting fibers.
